University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3

Phase 1

Terminated

Conditions: Cervical Cancer
Precancerous Condition

Interventions: Other: Placebo (Saline)
Drug: Zoledronate

First Posted Date: 2006-01-18

Last Posted Date: 2017-11-24

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 12

Registration Number: NCT00278434

Locations: 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

Evolution of Analgesic Tolerance With Opioids

Not Applicable

Completed

Conditions: Chronic Pain

First Posted Date: 2006-01-11

Last Posted Date: 2011-04-14

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 60

Registration Number: NCT00275249

Locations: 🇺🇸
UCSF Pain Clinical Research Center, San Francisco, California, United States

Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas

Phase 2

Completed

Conditions: Brain and Central Nervous System Tumors

First Posted Date: 2006-01-11

Last Posted Date: 2014-05-20

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 250

Registration Number: NCT00274755

Locations: 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

Efficacy Study of Subcutaneous Methyl-B12 in Children With Autism

Phase 2

Completed

Conditions: Autistic Disorder

Interventions: Other: saline placebo
Drug: methylcobalamin

First Posted Date: 2006-01-09

Last Posted Date: 2019-10-09

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 30

Registration Number: NCT00273650

Locations: 🇺🇸
UC Davis MIND Institute, Sacramento, California, United States

Staying Well: A Clinical Trial of Mindfulness-Based Stress Reduction and Education Groups for HIV

Phase 2

Completed

Conditions: HIV

Interventions: Behavioral: Mindfulness-Based Stress Reduction (MBSR)
Behavioral: HIV-education and self-management workshop

First Posted Date: 2006-01-04

Last Posted Date: 2012-04-17

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 177

Registration Number: NCT00271856

Locations: 🇺🇸
Osher Center for Integrative Medicine, San Francisco, California, United States

Drug Interaction Study Between Antimalarial and Anti-HIV Medications

Phase 1

Completed

Conditions: HIV Infections
Malaria

Interventions: Drug: Lopinavir/Ritonavir, Efavirenz, Artemether/lumefantrine

First Posted Date: 2005-12-15

Last Posted Date: 2013-06-06

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 33

Registration Number: NCT00266058

Locations: 🇺🇸
San Francisco General Hospital, San Francisco, California, United States

Valganciclovir to Reduce T Cell Activation in HIV Infection

Phase 4

Completed

Conditions: HIV Infections
Cytomegalovirus Infections

Interventions: Drug: Placebo
Drug: Valganciclovir

First Posted Date: 2005-12-12

Last Posted Date: 2020-07-31

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 30

Registration Number: NCT00264290

Locations: 🇺🇸
San Francisco General Hospital - General Clinical Research Center, San Francisco, California, United States

Effectiveness of Using Reduced Nicotine Cigarettes in Men and Women Smokers to Combat Nicotine Addiction

Completed

Conditions: Nicotine Dependence
Tobacco Use Disorder

First Posted Date: 2005-12-12

Last Posted Date: 2013-05-23

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 135

Registration Number: NCT00264342

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Integrating Buprenorphine Into the SFGH AIDS Program

Phase 4

Completed

Conditions: HIV
Buprenorphine
Opioid Dependence

Interventions: Other: Integrated office-based buprenorphine treatment for opioid dependence in an HIV primary care setting

First Posted Date: 2005-12-08

Last Posted Date: 2011-09-12

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 37

Registration Number: NCT00263458

Locations: 🇺🇸
UCSF Positive Health Program, San Francisco, California, United States

Bupropion for Hospital-Based Smoking Cessation

Phase 3

Completed

Conditions: Smoking

Interventions: Other: placebo
Drug: bupropion

First Posted Date: 2005-12-02

Last Posted Date: 2008-05-23

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 85

Registration Number: NCT00261170

Locations: 🇺🇸
Veterans Affairs Medical Center, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy